Autogenous (AVF) and prosthetic (AVG) arteriovenous fistulas are the vascular accesses (VA) of choice for hemodialysis thanks to their improved patency, reduced costs, and lower rate of infections relative to catheters.In an effort to maximize the number of primary AVF and AVG, shorten maturation times for AVF, and reduce the number of indwelling catheters, several new techniques have been developed within the context of an overall program designed to optimize access care.This approach includes: (a) Primary Intraoperative Balloon Angioplasty on the vessels selected for AV creation whether small-sized or altered by pre-existing lesions; (b) Percutaneous Transluminal Angioplasty (PTA) on AVF and AVG stenosis, performed under ultrasonographic (UG) or fluoroscopic guide (FG).We report the experience of two Center in performing the above mentioned procedures on even complex VA. The wise adoption of these techniques may avail to meet the stringent demands for reliable VA placement as defined by KDOQI and, thereby, expand the duration and quality of life for hemodialysis patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607312 | PMC |
| http://dx.doi.org/10.1177/1129729820977380 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Heamodialysis Arteriovenous Graft and the effect of obesity on patency. A Retrospective study.
Ann Vasc Surg
December 2024
Sheffield Kidney Institute, Northern General Hospital, Herries Road, Sheffield, United Kingdom, S5 7AU.
Obesity is growing in Haemodialysis population. Few scholars report variable effect of increased Body Mass Index (BMI) on native fistula. Reports on obesity effect on Arteriovenous Graft (AVG) patency are lacking.
View Article and Find Full Text PDFAdvancements in Mesenchymal Stem Cell-Based Therapy for Enhancing Arteriovenous Fistula Patency.
Int J Mol Sci
November 2024
Vascular and Interventional Radiology Translational Laboratory, Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Chronic kidney disease (CKD) affects more than 10% of the world's population. Hemodialysis, along with peritoneal dialysis and renal transplant, is one of the renal replacement therapies offered to patients with CKD/end-stage renal disease (ESRD). To proceed with hemodialysis, vascular access is required.
View Article and Find Full Text PDFSingle or Dual Antiplatelet Therapy Improves One-Year Arteriovenous Graft Patency and Overall Survival.
Ann Vasc Surg
November 2024
Division of Vascular and Endovascular Surgery, Department of Surgery, St Louis University, St Louis, MO.
Article Synopsis
- * A study involving nearly 50,000 AVF and 12,688 AVG patients assessed the impact of different anti-thrombotic therapies, showing SAPT yielded better outcomes compared to no antiplatelet treatment.
- * Dual antiplatelet therapy (DAPT) also improved primary patency for AVG patients, while the combination of aspirin and anticoagulation showed no significant benefits and had worse survival outcomes for both AVF and AVG patients.
Prevalence and Center Variability of Catheter-Based Hemodialysis in Vienna: Insights from the Vienna ACTS NOW Study.
J Clin Med
November 2024
Department of Vascular Surgery, Clinic Ottakring, 1160 Vienna, Austria.
Article Synopsis
- The study focuses on the use of central venous catheters (CVCs) in chronic hemodialysis patients in Vienna, noting that this practice is still common despite the preference for arteriovenous (AV) fistulas.
- A cross-sectional analysis of 335 CVC-based hemodialysis patients revealed a 42.5% prevalence of CVC use, with most patients eligible for either AV fistula or graft creation.
- The findings suggest that improving access to in-house vascular surgery could reduce reliance on CVCs and associated complications in hemodialysis patients in Vienna.
Blood osteoprotegerin is associated with arteriovenous access thrombosis in hemodialysis patients.
Kidney Res Clin Pract
October 2024
Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Background: A functioning arteriovenous (AV) access is essential for hemodialysis efficiency and the quality of life in hemodialysis patients. Blood osteoprotegerin (OPG) and soluble receptor activator of nuclear factor kappa B ligand (RANKL) have been linked to cardiovascular diseases and vascular calcification. This study investigated the relationship between blood OPG, RANKL, and the occurrence of AV access thrombosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!